 besity is reaching
epidemic proportions in the United States, and
psychotropic drugs may be important factors as both
causes and treatments for it.1-3 Beyond mere
monitoring of weight, psychiatrists who understand the
neuropharmacology of obesity may be able to exploit this
information to create clever drug selections, switches,
or combinations to mitigate or reverse psychotropic
drug-induced weight gain. Here we will discuss some tips
for applying the concepts of the psychopharmacologic
mechanisms relevant to psychotropic drug-induced changes
in body weight1 to the selection of
antidepressants and antipsychotics that can be risk
factors for obesity. |
|